Back
Dermata Therapeutics Stock Price Chart
The Next Tech Giant in Your Pocket?
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
17
DRMA
Dermata Therapeutics
Last Price:
1.93
Seasonality Move:
-51.46%
7 Day Trial
ALL ACCESS PASS
$
7
How this hedge fund manager trades weekly options
Claim your free training on trading weekly options- The current trend is relatively stagnant and DRMA is experiencing slight buying pressure.
Dermata Therapeutics Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 1.81 | Buy |
| 20-day SMA: | 1.74 | Buy |
| 50-day SMA: | 2.01 | Buy |
| 200-day SMA: | 5.05 | Sell |
| 8-day EMA: | 1.91 | Buy |
| 20-day EMA: | 1.85 | Buy |
| 50-day EMA: | 2.14 | Buy |
| 200-day EMA: | 9.07 | Sell |
Dermata Therapeutics Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.03 | Sell |
| Relative Strength Index (14 RSI): | 58.02 | Buy |
| Chaikin Money Flow: | 245155 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (1.55 - 2.07) | Buy |
| Bollinger Bands (100): | (1.68 - 3.98) | Sell |
Dermata Therapeutics Technical Analysis
| Sep 5 | Sep 6 | Sep 9 | Sep 10 | Sep 11 | Sep 12 | Sep 13 | Sep 16 | Sep 17 | Sep 18 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep | ||||||||||
| 05 | 06 | 09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Dermata Therapeutics Stock
Is Dermata Therapeutics Stock a Buy?
- Dermata Therapeutics share price is 2.25 while DRMA 8-day simple moving average is 1.81, which is a Buy signal.
- The stock price of DRMA is 2.25 while Dermata Therapeutics 20-day SMA is 1.74, which makes it a Buy.
- Dermata Therapeutics 50-day simple moving average is 2.01 while DRMA share price is 2.25, making it a Buy technically.
- DRMA stock price is 2.25 and Dermata Therapeutics 200-day simple moving average is 5.05, creating a Sell signal.
DRMA Technical Analysis vs Fundamental Analysis
Sell
17
Dermata Therapeutics (DRMA)
is a Sell
Is Dermata Therapeutics a Buy or a Sell?
-
Dermata Therapeutics stock is rated a Sell
The current Dermata Therapeutics [DRMA] share price is $2.25. The Score for DRMA is 17, which is 66% below its historic median score of 50, and infers higher risk than normal.
Dermata Therapeutics Stock Info
Market Cap:
2.96M
Price in USD:
2.25
Share Volume:
580.63K
Dermata Therapeutics 52-Week Range
52-Week High:
17.25
52-Week Low:
1.29
Sell
17
Dermata Therapeutics (DRMA)
is a Sell
Dermata Therapeutics Share Price Forecast
-
What is the Dermata Therapeutics stock price today?
The Dermata Therapeutics stock price is 2.25 USD today. -
Will DRMA stock go up or go down?
Dermata Therapeutics> share price is forecast to RISE/FALL based on technical indicators -
Is Dermata Therapeutics overvalued?
According to simple moving average, exponential moving average, oscillators, and other technical indicators, Dermata Therapeutics is overvalued.
Is Dermata Therapeutics Stock a Buy?
- Dermata Therapeutics share price is 2.25 while DRMA 8-day exponential moving average is 1.91, which is a Buy signal.
- The stock price of DRMA is 2.25 while Dermata Therapeutics 20-day EMA is 1.85, which makes it a Buy.
- Dermata Therapeutics 50-day exponential moving average is 2.14 while DRMA share price is 2.25, making it a Buy technically.
- DRMA stock price is 2.25 and Dermata Therapeutics 200-day simple moving average is 9.07, creating a Sell signal.
Technical Analysis of Dermata Therapeutics
Should I short Dermata Therapeutics stock?
- DRMA Moving Average Covergence Divergence (MACD) indicator is -0.03, suggesting Dermata Therapeutics is a Sell
- Dermata Therapeutics Relative Strength Index (RSI) is 58.02, which suggest Dermata Therapeutics is overbought
- The Bollinger Bands (25) for Dermata Therapeutics is (1.55 - 2.07), which suggest Dermata Therapeutics is a Sell
- The Bollinger Bands (100) for Dermata Therapeutics is (1.68 - 3.98), which suggest Dermata Therapeutics is a Sell
* Dermata Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.